To protect the health and safety of the public and our employees, DCP has limited on-site staffing at 450 Columbus Blvd. While mail and phone calls will be processed as quickly as possible, we recommend using our online services, or sending an email to the appropriate division/person instead. We apologize for any inconvenience.


Historically, a group of three products recently encountered on the designer drug market:

    • 25I-NBOMe
    • 25C-NBOMe
    • 25B-NBOMe

  • Classification: Hallucinogenic, LSD-like, they target the same Serotonin receptor sites as LSD

  • Availability: In-line and through illicit channels. Available as powders, liquids, laced on edible items, and blotter papers

  • Observed Behavior: Hallucinations

  • Observed Negative Effects: In higher doses, seizures, cardiac and respiratory arrest and death

  • Street Names:  
    • N-bomb
    • Smiles
    • 25I
    • 25C
    • 25B

  • Street Pricing:   Unknown

  • Schedule:   Not currently scheduled, if intended for human consumption, may each be treated as a “controlled substance analog” under the Controlled Substance Act   21 U.S.C. 802(32)(A) and 813

  •   Charges:   See schedule above